LONDON (Reuters) - Scientists have used an "artificial pancreas" system of pumps and monitors to improve blood sugar control in diabetes patients in the first study to show the new device works better than conventional treatment. Researchers from Britain's Cambridge University tested the device on 17 children with type 1 diabetes during a series of nights in hospital and found ...

NEW YORK (Reuters Health) - Pumps that deliver insulin to the body as needed may be more effective than insulin injections for helping people with type 1 diabetes keep their blood sugar under control, according to a new review of 23 studies comparing the two approaches. But the analysis didn't provide evidence on the risk of complications and the costs ...

An experimental artificial pancreas will soon be tested in diabetes patients, potentially sparing them the hormonal disorder's most dangerous complications and frequent blood sugar checks and insulin injections. If all goes well, a commercial model could be on the market in four years, said Aaron Kowalski, research director of the Juvenile Diabetes Research Foundation's artificial pancreas project. The ...

WASHINGTON (Reuters) - Diabetes advocates and a company that makes insulin pumps announced plans on Wednesday to team up to make a so-called artificial pancreas -- a system of pumps and monitors to manage type-1 diabetes. The Juvenile Diabetes Research Foundation said it had chosen Johnson & Johnson unit Animas to develop and test the new system. "This is going to be ...